Shelley Hartman

Chief Executive Officer, Co-Founder

Shelley Hartman serves as CEO of Aegle Therapeutics Corporation, a first-in-class, Phase 1/2a-ready biotechnology company isolating extracellular vesicles from allogeneic bone marrow derived mesenchymal stem cells to treat severe dermatological conditions. Prior to Aegle, Shelley served as Chairman and CEO of LifeSync Holdings, a diversified biotech/medtech development company, and CEO of LifeSync Corporation, an innovative medical device start-up company providing wireless technology to hospital customers.

A former Managing Director in the Investment Banking Division of Goldman Sachs & Co., Shelley has extensive experience in corporate strategy, M&A and capital raising in the healthcare industry.

Talks About
#management

Preferred Locations
#Northamerica